Velsera Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 813

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 3

  • Investments
  • 3

Velsera General Information

Description

Operator of a research and development company intended for the healthcare and life science industries. The company transforms science, technology and informatics into an ecosystem of insight, making data actionable through integrating a software platform, domain expertise and knowledge that accelerates the pace and potential of multi-omics.

Contact Information

Website
www.velsera.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 145 Tremont Street
  • Suite 201
  • Boston, MA 02111
  • United States
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 145 Tremont Street
  • Suite 201
  • Boston, MA 02111
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Velsera Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Velsera‘s full profile, request access.

Request a free trial

Velsera Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Velsera Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Velsera‘s full profile, request access.

Request a free trial

Velsera Investments (3)

Velsera’s most recent deal was a Buyout/LBO with UgenTec. The deal was made on 06-Sep-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
UgenTec 06-Sep-2022 Buyout/LBO Enterprise Systems (Healthcare)
PierianDx 01-Aug-2022 Buyout/LBO Decision/Risk Analysis
Seven Bridges Genomics 07-Jun-2022 Buyout/LBO Enterprise Systems (Healthcare)
To view Velsera’s complete investments history, request access »

Velsera Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
UgenTec Hasselt, Belgium 2014
PierianDx Creve Coeur, MO 2014

Velsera FAQs

  • When was Velsera founded?

    Velsera was founded in 2023.

  • Where is Velsera headquartered?

    Velsera is headquartered in Boston, MA.

  • What is the size of Velsera?

    Velsera has 813 total employees.

  • What industry is Velsera in?

    Velsera’s primary industry is Biotechnology.

  • Is Velsera a private or public company?

    Velsera is a Private company.

  • What is Velsera’s current revenue?

    The current revenue for Velsera is .

  • Who are Velsera’s investors?

    ATW Partners, Health Catalyst Capital Management, OrbiMed, SJF Ventures, and Summa Equity are 5 of 6 investors who have invested in Velsera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process